BrainStorm Announces Presentations at June 2022 Scientific Conferences
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announces...
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announces...
WASHINGTON, May 31, 2022 /PRNewswire/ -- With more than 28,000 cases of multiple sclerosis reported to the Department of Veterans Affairs annually...
-- Data being presented at the CMSC Annual Meeting demonstrates UPLIZNA may reduce attack risk and disability among populations with genetic variables typically linked to poor treatment response
Emotional or sexual abuse in childhood may increase risk for multiple sclerosis in women, and multiple kinds of abuse is tied to further risk, the first prospective study of its kind suggests.
/PRNewswire/ -- NeurologyLive®, a multimedia platform dedicated to providing health care professionals with direct access to expert-driven, practice-changing...